# Advanced Micro Devices Inc: financial statements, quarterly

AMD · Nasdaq · CIK 2488 · [Technology](/sectors/technology.md) · fiscal year ends Dec 26

Pages: [Overview](/companies/amd.md) · [Financials](/companies/amd/financials.md) · [Filings](/companies/amd/filings.md) · [Insiders](/companies/amd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [5.8](/filings/0000002488-24-000163.md) | [6.2 d](/filings/0000002488-26-000018.md) | [5.5](/filings/0000002488-25-000047.md) | [5.8](/filings/0000002488-25-000108.md) | [6.8](/filings/0000002488-25-000166.md) | [7.7 d](/filings/0000002488-26-000018.md) | [7.4](/filings/0000002488-26-000076.md) | [7.7](/filings/0000002488-26-000123.md) | [9.2](/filings/0000002488-25-000166.md) | [10.3 d](/filings/0000002488-26-000018.md) | [10.3](/filings/0000002488-26-000076.md) | [11.5](/filings/0000002488-26-000123.md) |
| Cost of revenue | $bn | [3.1](/filings/0000002488-24-000163.md) | [3.3 d](/filings/0000002488-26-000018.md) | [2.9](/filings/0000002488-25-000047.md) | [3.0](/filings/0000002488-25-000108.md) | [3.4](/filings/0000002488-25-000166.md) | [3.8 d](/filings/0000002488-26-000018.md) | [3.7](/filings/0000002488-26-000076.md) | [4.6](/filings/0000002488-26-000123.md) | [4.5](/filings/0000002488-25-000166.md) | [4.7 d](/filings/0000002488-26-000018.md) | [4.8](/filings/0000002488-26-000076.md) | [5.3](/filings/0000002488-26-000123.md) |
| Gross profit | $bn | [2.7](/filings/0000002488-24-000163.md) | [2.9 d](/filings/0000002488-26-000018.md) | [2.6](/filings/0000002488-25-000047.md) | [2.9](/filings/0000002488-25-000108.md) | [3.4](/filings/0000002488-25-000166.md) | [3.9 d](/filings/0000002488-26-000018.md) | [3.7](/filings/0000002488-26-000076.md) | [3.1](/filings/0000002488-26-000123.md) | [4.8](/filings/0000002488-25-000166.md) | [5.6 d](/filings/0000002488-26-000018.md) | [5.4](/filings/0000002488-26-000076.md) | [6.2](/filings/0000002488-26-000123.md) |
| Research and development | $bn | [1.5](/filings/0000002488-24-000163.md) | [1.5 d](/filings/0000002488-26-000018.md) | [1.5](/filings/0000002488-25-000047.md) | [1.6](/filings/0000002488-25-000108.md) | [1.6](/filings/0000002488-25-000166.md) | [1.7 d](/filings/0000002488-26-000018.md) | [1.7](/filings/0000002488-26-000076.md) | [1.9](/filings/0000002488-26-000123.md) | [2.1](/filings/0000002488-25-000166.md) | [2.3 d](/filings/0000002488-26-000018.md) | [2.4](/filings/0000002488-26-000076.md) | [2.5](/filings/0000002488-26-000123.md) |
| Selling, general and administrative | $bn | [0.6](/filings/0000002488-24-000163.md) | [0.6 d](/filings/0000002488-26-000018.md) | [0.6](/filings/0000002488-25-000047.md) | [0.6](/filings/0000002488-25-000108.md) | [0.7](/filings/0000002488-25-000166.md) | [0.8 d](/filings/0000002488-26-000018.md) | [0.9](/filings/0000002488-26-000076.md) | [1.0](/filings/0000002488-26-000123.md) | [1.1](/filings/0000002488-25-000166.md) | [1.2 d](/filings/0000002488-26-000018.md) | [1.3](/filings/0000002488-26-000076.md) | [1.4](/filings/0000002488-26-000123.md) |
| Operating income | $bn | [0.2](/filings/0000002488-24-000163.md) | [0.3 d](/filings/0000002488-26-000018.md) | [0.0](/filings/0000002488-25-000047.md) | [0.3](/filings/0000002488-25-000108.md) | [0.7](/filings/0000002488-25-000166.md) | [0.9 d](/filings/0000002488-26-000018.md) | [0.8](/filings/0000002488-26-000076.md) | [(0.1)](/filings/0000002488-26-000123.md) | [1.3](/filings/0000002488-25-000166.md) | [1.8 d](/filings/0000002488-26-000018.md) | [1.5](/filings/0000002488-26-000076.md) | [2.0](/filings/0000002488-26-000123.md) |
| Interest expense | $bn | [0.0](/filings/0000002488-24-000163.md) | [0.0 d](/filings/0000002488-26-000018.md) | [0.0](/filings/0000002488-25-000047.md) | [0.0](/filings/0000002488-25-000108.md) | [0.0](/filings/0000002488-25-000166.md) | [0.0 d](/filings/0000002488-26-000018.md) | [0.0](/filings/0000002488-26-000076.md) | [0.0](/filings/0000002488-26-000123.md) | [0.0](/filings/0000002488-25-000166.md) | [0.0 d](/filings/0000002488-26-000018.md) | [0.0](/filings/0000002488-26-000076.md) | [0.0](/filings/0000002488-26-000123.md) |
| Income tax | $bn | [(0.0)](/filings/0000002488-24-000163.md) | [(0.3) d](/filings/0000002488-26-000018.md) | [(0.1)](/filings/0000002488-25-000047.md) | [0.0](/filings/0000002488-25-000108.md) | [(0.0)](/filings/0000002488-25-000166.md) | [0.4 d](/filings/0000002488-26-000018.md) | [0.1](/filings/0000002488-26-000076.md) | [(0.8)](/filings/0000002488-26-000123.md) | [0.2](/filings/0000002488-25-000166.md) | [0.5 d](/filings/0000002488-26-000018.md) | [0.2](/filings/0000002488-26-000076.md) | [0.3](/filings/0000002488-26-000123.md) |
| Net income | $bn | [0.3](/filings/0000002488-24-000163.md) | [0.7 d](/filings/0000002488-26-000018.md) | [0.1](/filings/0000002488-25-000047.md) | [0.3](/filings/0000002488-25-000108.md) | [0.8](/filings/0000002488-25-000166.md) | [0.5 d](/filings/0000002488-26-000018.md) | [0.7](/filings/0000002488-26-000076.md) | [0.9](/filings/0000002488-26-000123.md) | [1.2](/filings/0000002488-25-000166.md) | [1.5 d](/filings/0000002488-26-000018.md) | [1.4](/filings/0000002488-26-000076.md) | [2.3](/filings/0000002488-26-000123.md) |
| Diluted EPS | $ per share | [0.18](/filings/0000002488-24-000163.md) | not reported | [0.07](/filings/0000002488-25-000047.md) | [0.16](/filings/0000002488-25-000108.md) | [0.47](/filings/0000002488-25-000166.md) | not reported | [0.44](/filings/0000002488-26-000076.md) | [0.54](/filings/0000002488-26-000123.md) | [0.75](/filings/0000002488-25-000166.md) | not reported | [0.84](/filings/0000002488-26-000076.md) | [1.38](/filings/0000002488-26-000123.md) |
| Basic EPS | $ per share | [0.18](/filings/0000002488-24-000163.md) | not reported | [0.08](/filings/0000002488-25-000047.md) | [0.16](/filings/0000002488-25-000108.md) | [0.48](/filings/0000002488-25-000166.md) | not reported | [0.44](/filings/0000002488-26-000076.md) | [0.54](/filings/0000002488-26-000123.md) | [0.76](/filings/0000002488-25-000166.md) | not reported | [0.85](/filings/0000002488-26-000076.md) | [1.40](/filings/0000002488-26-000123.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.6](/filings/0000002488-23-000195.md) | [3.9](/filings/0000002488-26-000018.md) | [4.2](/filings/0000002488-24-000056.md) | [4.1](/filings/0000002488-24-000123.md) | [3.9](/filings/0000002488-24-000163.md) | [3.8](/filings/0000002488-26-000018.md) | [6.0](/filings/0000002488-25-000047.md) | [4.4](/filings/0000002488-25-000108.md) | [4.8](/filings/0000002488-25-000166.md) | [5.5](/filings/0000002488-26-000123.md) | [5.6](/filings/0000002488-26-000076.md) | [5.1](/filings/0000002488-26-000123.md) |
| Current assets | $bn | [16.7](/filings/0000002488-23-000195.md) | [16.8](/filings/0000002488-25-000012.md) | [17.1](/filings/0000002488-24-000056.md) | [17.5](/filings/0000002488-24-000123.md) | [18.7](/filings/0000002488-24-000163.md) | [19.0](/filings/0000002488-26-000018.md) | [21.6](/filings/0000002488-25-000047.md) | [24.5](/filings/0000002488-25-000108.md) | [27.0](/filings/0000002488-25-000166.md) | [26.9](/filings/0000002488-26-000123.md) | [28.6](/filings/0000002488-26-000076.md) | [31.5](/filings/0000002488-26-000123.md) |
| Total assets | $bn | [67.6](/filings/0000002488-23-000195.md) | [67.9](/filings/0000002488-25-000012.md) | [67.9](/filings/0000002488-24-000056.md) | [67.9](/filings/0000002488-24-000123.md) | [69.6](/filings/0000002488-24-000163.md) | [69.2](/filings/0000002488-26-000018.md) | [71.6](/filings/0000002488-25-000047.md) | [74.8](/filings/0000002488-25-000108.md) | [76.9](/filings/0000002488-25-000166.md) | [76.9](/filings/0000002488-26-000123.md) | [79.6](/filings/0000002488-26-000076.md) | [84.5](/filings/0000002488-26-000123.md) |
| Current liabilities | $bn | [7.6](/filings/0000002488-23-000195.md) | [6.7](/filings/0000002488-25-000012.md) | [6.5](/filings/0000002488-24-000056.md) | [6.2](/filings/0000002488-24-000123.md) | [7.5](/filings/0000002488-24-000163.md) | [7.3](/filings/0000002488-26-000018.md) | [7.7](/filings/0000002488-25-000047.md) | [9.8](/filings/0000002488-25-000108.md) | [11.7](/filings/0000002488-25-000166.md) | [9.5](/filings/0000002488-26-000123.md) | [10.5](/filings/0000002488-26-000076.md) | [12.1](/filings/0000002488-26-000123.md) |
| Long-term debt | $bn | [1.7](/filings/0000002488-23-000195.md) | [1.7](/filings/0000002488-25-000012.md) | [1.7](/filings/0000002488-24-000056.md) | [1.7](/filings/0000002488-24-000123.md) | [1.7](/filings/0000002488-24-000163.md) | [1.7](/filings/0000002488-26-000018.md) | [3.2](/filings/0000002488-25-000047.md) | [3.2](/filings/0000002488-25-000108.md) | [2.3](/filings/0000002488-25-000166.md) | [2.3](/filings/0000002488-26-000123.md) | [2.4](/filings/0000002488-26-000076.md) | [2.4](/filings/0000002488-26-000123.md) |
| Current portion of debt | $bn | [0.8](/filings/0000002488-23-000195.md) | [0.8](/filings/0000002488-25-000012.md) | [0.8](/filings/0000002488-24-000056.md) | [0.0](/filings/0000002488-24-000123.md) | [0.0](/filings/0000002488-24-000163.md) | [0.0](/filings/0000002488-26-000018.md) | not reported | not reported | [0.9](/filings/0000002488-25-000166.md) | [0.9](/filings/0000002488-26-000123.md) | [0.9](/filings/0000002488-26-000076.md) | [0.9](/filings/0000002488-26-000123.md) |
| Short-term borrowings | $bn | [0.8](/filings/0000002488-23-000195.md) | [0.8](/filings/0000002488-25-000012.md) | [0.8](/filings/0000002488-24-000056.md) | [0.0](/filings/0000002488-24-000123.md) | [0.0](/filings/0000002488-24-000163.md) | [0.0](/filings/0000002488-26-000018.md) | [0.9](/filings/0000002488-25-000047.md) | not reported | not reported | [0.9](/filings/0000002488-26-000018.md) | not reported | not reported |
| Shareholders' equity | $bn | [55.0](/filings/0000002488-24-000163.md) | [55.9](/filings/0000002488-26-000018.md) | [56.2](/filings/0000002488-25-000047.md) | [56.5](/filings/0000002488-25-000108.md) | [57.0](/filings/0000002488-25-000166.md) | [57.6](/filings/0000002488-26-000018.md) | [57.9](/filings/0000002488-26-000076.md) | [59.7](/filings/0000002488-26-000123.md) | [60.8](/filings/0000002488-25-000166.md) | [63.0](/filings/0000002488-26-000123.md) | [64.5](/filings/0000002488-26-000076.md) | [67.2](/filings/0000002488-26-000123.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [421 d](/filings/0000002488-24-000163.md) | [381 d](/filings/0000002488-26-000018.md) | [521](/filings/0000002488-25-000047.md) | [593 d](/filings/0000002488-25-000108.md) | [628 d](/filings/0000002488-25-000166.md) | [1,299 d](/filings/0000002488-26-000018.md) | [939](/filings/0000002488-26-000076.md) | [2,011 d](/filings/0000002488-26-000123.md) | [2,159 d](/filings/0000002488-25-000166.md) | [2,600 d](/filings/0000002488-26-000018.md) | [2,955](/filings/0000002488-26-000076.md) | [2,366 d](/filings/0000002488-26-000123.md) |
| Capital expenditure | $m | [124 d](/filings/0000002488-24-000163.md) | [139 d](/filings/0000002488-26-000018.md) | [142](/filings/0000002488-25-000047.md) | [154 d](/filings/0000002488-25-000108.md) | [132 d](/filings/0000002488-25-000166.md) | [208 d](/filings/0000002488-26-000018.md) | [212](/filings/0000002488-26-000076.md) | [282 d](/filings/0000002488-26-000123.md) | [258 d](/filings/0000002488-25-000166.md) | [222 d](/filings/0000002488-26-000018.md) | [389](/filings/0000002488-26-000076.md) | [808 d](/filings/0000002488-26-000123.md) |
| Share repurchases | $m | [511 d](/filings/0000002488-24-000163.md) | [233 d](/filings/0000002488-26-000018.md) | [4.0](/filings/0000002488-25-000047.md) | [352 d](/filings/0000002488-25-000108.md) | [250 d](/filings/0000002488-25-000166.md) | [256 d](/filings/0000002488-26-000018.md) | [749](/filings/0000002488-26-000076.md) | [478 d](/filings/0000002488-26-000123.md) | [89.0 d](/filings/0000002488-25-000166.md) | [0.0 d](/filings/0000002488-26-000018.md) | [221](/filings/0000002488-26-000076.md) | [0.0 d](/filings/0000002488-26-000123.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-24) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,625](/filings/0000002488-23-000195.md) | [1,611](/filings/0000002488-24-000056.md) | [1,627](/filings/0000002488-24-000123.md) | [1,629](/filings/0000002488-24-000163.md) | [1,639](/filings/0000002488-25-000047.md) | [1,637](/filings/0000002488-25-000108.md) | [1,636](/filings/0000002488-25-000166.md) | [1,626](/filings/0000002488-26-000076.md) | [1,630](/filings/0000002488-26-000123.md) | [1,641](/filings/0000002488-25-000166.md) | [1,650](/filings/0000002488-26-000076.md) | [1,659](/filings/0000002488-26-000123.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,632,475,042 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0000002488-26-000123.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.